Esperion Therapeutics
ESPR
ESPR
199 hedge funds and large institutions have $560M invested in Esperion Therapeutics in 2025 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 83 increasing their positions, 34 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
9.73% more ownership
Funds ownership: 53.55% → 63.28% (+9.7%)
6% more funds holding
Funds holding: 187 → 199 (+12)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
199
Holding in Top 10
1
Calls
$19.2M
Puts
$4.26M
Top Buyers
| 1 | +$21.6M | |
| 2 | +$19.3M | |
| 3 | +$12.4M | |
| 4 |
Millennium Management
New York
|
+$9.56M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$9.53M |
Top Sellers
| 1 | -$7.38M | |
| 2 | -$3.98M | |
| 3 | -$3.01M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.91M |
| 5 |
Jane Street
New York
|
-$2.82M |
